Janux Therapeutics, Inc. (JANX) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$113.62M | -64.7% |
| 2024 | -$68.99M | -18.4% |
| 2023 | -$58.29M | +7.6% |
| 2022 | -$63.06M | -93.0% |
| 2021 | -$32.67M | -381.6% |
| 2020 | -$6.78M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$113.62M | -64.7% |
| 2024 | -$68.99M | -18.4% |
| 2023 | -$58.29M | +7.6% |
| 2022 | -$63.06M | -93.0% |
| 2021 | -$32.67M | -381.6% |
| 2020 | -$6.78M | — |